Canopy Growth Business Summary

Canopy Growth Corporation (CGC) generates revenue primarily through the sale of adult-use and medical cannabis in Canada, international cannabis exports, and the global distribution of vaporization technology via its Storz & Bickel subsidiary. The company’s business is organized into three core segments: Canada Cannabis (Adult-Use and Medical), International Markets (principally Germany, Poland, and Australia), and Consumer Products (Storz & Bickel and This Works). A pivotal element of its current strategy is the 'Canopy USA' ecosystem, which enables the company to maintain a non-controlling interest in U.S. cannabis entities such as Acreage, Wana, and Jetty, positioning it for immediate entry upon federal legalization. Canopy competes directly with Tilray Brands, Aurora Cannabis, Cronos Group, and SNDL Inc., distinguishing itself as a premium-focused operator that has successfully pivoted to an asset-light model, achieving a net cash position and narrowing losses significantly as of Q3 FY2026. Originally founded in 2013 by Bruce Linton, Chuck Rifici, and Mark Zekulin, Canopy Growth is now led by CEO Luc Mongeau, a consumer packaged goods expert who joined in early 2025 following leadership roles at Weston Foods and Mars Petcare. The senior leadership team includes CFO Tom Stewart, who managed the company’s 2026 strategic recapitalization, and Dr. Christelle Gedeon, Chief Business Development Officer. The Board of Directors, chaired by David Lazzarato, features prominent industry figures such as Terry Yanofsky and Joe Bayern. The company’s most notable institutional partner is Constellation Brands (STZ), which remains a major shareholder and strategic ally, providing the financial foundation for Canopy’s recent acquisition of MTL Cannabis and its ongoing pursuit of Adjusted EBITDA profitability in fiscal 2027.